I had been struck by Booth's chapter in the first series volume of Recent advances in gastroenterology, entitled Physiopathology of intestinal malabsorption,' in which he focussed on the striking differences between 'flat' and 'convoluted' coeliac mucosae as had been recently revealed through the 'dissecting' microscope. Importantly, the question arose as to whether each type of surface structure could be inter-related and hence part of the same pathological process. What was needed was some other technique endowed with high resolving power to show that these stages were distinctive, yet progressive, phases in the natural evolution of the coeliac lesion. Fortunately, the necessary technique for tackling this problem came with the introduction of the first commercial scanning electron microscope by Cambridge (Scientific) Instruments. 2 The rest was easy. Nevertheless, at the time, I had no premonition that within a few years I should be asked by the editors to contribute,3 in the second volume of Recent advances, some of the findings that had arisen from my research with Chris (Fig 1) . Despite such successes, particularly at a time when the scanning electron microscope had hardly realised its full potential as an experimental research tool, the work failed to provide clues about pathogenetic mechanisms concerned in mucosal flattening.
In the early 70s, however, interest in the immunological behaviour of the intestine was increasing. More specifically, the demonstration by Anne Ferguson that the local tissue density of intraepithelial lymphocytes (IEL) is increased in untreated coeliac disease mucosae (note that in numerical terms the absolute population of IEL was subsequently shown to be reduced) was one of the first major studies suggestive of an immunological component in pathogenesis. 4 Figure 3 : Three distinctive patterns in mucosal immunopathology occur at either end ofthe gluten-sensitive spectrum. The 'infiltrative' (type 1) lesion, comprising normal crypts and villi, reveals infiltration ofvillous epithelium only by small, non-mitotic lymphocytes. It occurs in somefirst degree relatives ofcoeliac disease patients, and after small dose gluten challenge ofcoeliac patients in remission. The 'hyperplastic' (type 2) lesion, comprising normal villi and hyperplastic crypts that are both infiltrated by small and essentially non-mitotic lymphocytes, is seen in some DH patients without enteropathy, and is inducible in treated coeliac patients by moderate dose gluten challenge. The 'destructive' (type 3) lesion shows villous effacement and markedly hypertrophied crypts containing a population oflarge, mitotic lymphocytes. This lesion is typical of untreated coeliac disease and of30-40% DH patients with enteropathy, and can be reproduced by high dose gluten challenge ofwell-treated coeliac patients. In the tropics, the majority ofindividuals exposed to a heavy intestinal microbial population develop an asymptomatic type I delayed-type (cell-mediated) intestinal lesion. Among these are presumably some people who, in due time and because of? genetic factors, are predisposed to develop theflatter type 3 lesion oftropical sprue, associated wnth severe malabsorption. In intestinal giardiasis, some individuals may be apparently unaffected while others develop a characteristic type I lesion: only rarely is the 'flat' type 3 lesion evident.
the initial infiltrative stage is analogous to that observed experimentally in mild graft-versushost lesions. 12 At the later stage, villous flattening is accompanied by a reduction in the absolute number of IEL which become larger and more actively mitotic. These features are similar to those seen in untreated coeliac patients, and to those elicited by severe graft-versus-host lesions.'3 A similar series of changes can be defined with a sufficiently large series ofmucosae from untreated patients with dermatitis herpetiformis,'4 when arranged in descending order of surface epithelial volume. Analogous changes also occur spontaneously in the evolution of a flat mucosa in coeliac patients. '5 Conclusions It is now evident that distinctive mucosal patterns typify experimental cell-mediated (T lymphocyte) reactions in small intestinal mucosa 16 -the type 1 ('infiltrative') lesion, type 2 ('hyperplastic') lesion and the type 3 ('destructive') lesion (Fig 3) . Similar lesions have been identified in coeliac and dermatitis herpetiformis patients, in some first degree coeliac relatives, and can be induced progressively during oral gluten challenges. These latter studies indicate (like the experimental models) that the development of a type 3 lesion requires transition through the milder type 1 and 2 lesions in which crypt hyperplasia (and hypertrophy) is an early and prominent feature. Recent work indicates that crypt hypertrophy is a rapid response to activation of lamina propria T cells in cultured fetal human intestinal explants. ' (Fig 4) . These observations provide the framework for distinguishing, on routine histopathology, 'early' or 'late' phase intestinal reactions to a variety of environmental antigens. Perhaps for the future, we should re-evaluate our perception of intestinal pathology in such terms, rather than by the continued use of subjective degrees of 'villous atrophy'. Such latter terminology no longer serves a useful purpose and moreover, obscures recognition of the fundamental changes occurring within small bowel mucosae in these conditions. environmental antigen challenge. 
